Data / Form D filings / Aureon Biosciences, Inc.
Aureon Biosciences, Inc.: Form D filings
Aureon Biosciences, Inc., a biotechnology company in Yonkers, NY, filed 7 Form D notices with the SEC between 2009 and 2011. The latest, on September 29, 2011, reports $16.8 million sold of a $17.1 million offering to 17 investors.
Find out what Aureon Biosciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 28 WELLS AVE, Yonkers, NY, 10701
- Phone
- (914) 377-4000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1331514
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2011 | Amendment | $17,100,000 | $16,835,103 | $264,897 | 17 | Oct 12, 2010 | sec.gov |
| Jun 1, 2011 | Amendment | $15,000,000 | $12,996,438 | $2,003,562 | 17 | Oct 12, 2010 | sec.gov |
| Oct 25, 2010 | New notice | $10,000,000 | $4,996,439 | $5,003,561 | 17 | Oct 12, 2010 | sec.gov |
| Aug 13, 2010 | New notice | $2,999,961 | $2,999,961 | $0 | 17 | Aug 9, 2010 | sec.gov |
| Mar 2, 2010 | New notice | $17,999,788 | $6,999,918 | $10,999,870 | 17 | Feb 23, 2010 | sec.gov |
| Jan 14, 2010 | New notice | $2,500,000 | $2,500,000 | $0 | 16 | Jan 11, 2010 | sec.gov |
| Aug 7, 2009 | New notice | $8,000,000 | $4,000,000 | $4,000,000 | 16 | Jul 29, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jose Costa, M.D. | Director | |
| Paul Veronese | Director | |
| Robert Shovlin | Executive Officer, Director | |
| Peter Barrett, Ph.D. | Director | |
| William Burkoth | Director | |
| Carlos Cordon-Cardo, M.D., Ph.D. | Director | |
| Philippe Chambon, M.D., Ph.D. | Director | |
| Kevin Johnson | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Sep 26, 2011 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aureon Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.